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Understanding the treatment of 
allergic rhinitis
EDITORIAL
At this time of the year, in some Brazilian regions 
(Southeast and Mid-West), the weather becomes very dry, 
and in some cities, the level of air pollution is substantially 
bad. These factors, amongst others, contribute to a worse-
ning in the symptoms of those patients with inflammatory 
rhinitis, and they may become predisposed to developing 
infectious rhinitis. 
According to ARIA (Allergic Rhinitis And Its Impact 
on Asthma), rhinitis is an inflammatory process that affects 
the nasal mucosa, causing nasal obstruction, anterior and/
or posterior rhinorrhea, sneezing and nasal pruritus, oc-
curring for more than two consecutive days and lasting 
for more than one hour in most days.
In allergic rhinitis, the inflammatory process starts 
with the Type I reaction of Gell and Coobs’s classification. 
In genetically predisposed individuals, they will produce 
immunoglobulin E (IgE) for some antigens. The interac-
tion between these antibodies (linked to mast cells) and 
the antigens results in the release of numerous mediators 
(histamine, leukotrienes, etc.) which act on receptors to 
trigger the symptoms. Moreover, some of them are capa-
ble of attracting inflammatory cells (eosinophils) for the 
region (nasal mucosa), which will be activated and will 
release their mediators (eosinophillic cationic protein, 
eosinophillic peroxidase, etc.), responsible for local in-
flammation.
Physiologically speaking, nasal breathing has a 
cycle, while one of the nasal cavities is more resistant to 
air flow (obstructed), the other remains patent. The sti-
muli responsible for vasodilatation also cause increase in 
glandular secretion and stimulate cilia beating. After a few 
hours (2 to 6) the one that was obstructed starts to receive 
vasoconstriction stimuli, and vice-versa. This physiological 
nasal cycle is controlled by the autonomic nervous system 
(ANS), which is altered by rhinitis. Such patients have 
a local sympathetic hyporeactivity and parasympathetic 
hyperactivity, consequently presenting symptoms caused 
by unspecific stimuli (changes in temperature or in air 
moisture, etc). 
In patients with allergic rhinitis we also find neuro-
genic inflammation. Some neuropeptides secreted by the 
ANS (NPY) cause the release of interleukins, which are 
directly associated with allergies, such as IL-3, IL-4 and 
IL-5. While IL-4 is important in inducing the expression of 
adhesion molecules associated with eosinophil attraction, 
IL-3 and 5 are responsible for its activation and apoptosis 
reduction.
Understanding such concepts can help treat patients 
with allergic rhinitis. In other words, since they simulta-
neously present local hyperactivity towards specific and 
unspecific agents (Figure 1), the physician’s role is to iden-
tify the relevance of each of these mechanisms that cause 
symptoms. This must be considered when one chooses 
the drug treatment, because if IgE-mediated symptoms 
prevail, the response to anti-histamines and chromones, 
for example, will be better than in those cases in which 
ANS hyperactivity is more important.
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Figure 1- Legend: relevance of allergy and autonomic nervous sys-
tem mechanisms in the cause of symptoms of patients with allergic 
rhinitis.
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